Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where A. Bellomo is active.

Publication


Featured researches published by A. Bellomo.


Archives of Gerontology and Geriatrics | 2009

Is there a relationship between high C-reactive protein (CRP) levels and dementia?

A. Mancinella; M. Mancinella; G. Carpinteri; A. Bellomo; V. Gianturco; A. Iori; Evaristo Ettorre; G. Troisi; Vincenzo Marigliano

Inflammation is believed to play a pivotal role in dementia, but its role is still unclear. The aim of our study was to analyze the interplay among markers of inflammation, such as fibrinogen and high CRP levels, and dementia. First, we performed a cross-sectional study comparing markers of inflammation between 99 patients affected by dementia (mean age: 83.0+/-0.6 years) and 99 controls (mean age: 83.9+/-0.7 years). Then, we analyzed the relationship between inflammation and dementia in the same population composed by 34 Alzheimers disease (AD) patients (mean age: 83.4+/-0.8 years), 64 vascular dementia (VaD) patients (mean age: 82.7+0.8 years) and 99 controls. Patients affected by dementia had higher CRP levels than controls (2.6+/-+/-0.2 vs. 0.7 + 0.1 p < 0.001, respectively). AD patients had higher CRP levels than VaD patients (4.2 + 0.6 vs. 1.7+/-0.2, p < 0.001, respectively). Stepwise multiple logistic regression analysis showed that dementia (odds ratio=OR=4.965, 95% confidence interval=Cl=1.402-13.23, p=0.004), fibrinogen (OR=1.011, Cl=1.007-1.015, p<0.001), and age (OR=1.158, Cl=1.063-1.261, p<0.001) are independently correlated with high levels of CRP. The study suggests that inflammation may have a pathogenetic role in AD.


Archives of Gerontology and Geriatrics | 2009

IMPACT OF THERAPY WITH α-LIPOIC ACID (ALA) ON THE OXIDATIVE STRESS IN THE CONTROLLED NIDDM: A POSSIBLE PREVENTIVE WAY AGAINST THE ORGAN DYSFUNCTION?

V. Gianturco; A. Bellomo; E. D’ottavio; V. Formosa; A. Iori; M. Mancinella; G. Troisi; Vincenzo Marigliano

There is a growing evidence that excess generation of highly reactive free radicals, largely due to hyperglycemia, causes oxidative stress, which further exacerbates the development and progression of diabetes and its complications. The purpose of this study was to evaluate the impact of ALA on lipid profile, oxidative pattern and inflammation in patients with controlled non-insulin dependent diabetes mellitus (NIDDM). ALA, 400mg/day was investigated in NIDDM patients over a period of 4 weeks using a randomized, placebo-(PLA)-controlled study with two parallel groups. The marker of oxidative stress was the concentration of reactive oxygen metabolites, evaluated using a commercially available test, called d-ROMs test, and the biological antioxidant potential (BAP); besides, the lipid profile (total cholesterol=TC, high-density lipoprotein-cholesterol = HDL-C; low-density lipoprotein-cholesterol=LDL-C, and triglycerides=TG) and the C-reactive protein (CRP), marker of inflammation were measured at the beginning and at the end of the treatment. A total of 14 patients were randomly assigned to the two groups. ALA was safe and well tolerated in the only oral daily administration. The d-ROMs test (p=0.03) and HDL-C (p=0.04) showed a significant difference between the two groups. BAP (p=0.06) tended to be higher in the treated patients, while LDL-C (p=0.07) presented a moderate decline. There were no significant differences in TC (p=0.65), TG (p=0.78) and CRP (p=0.96) between the ALA and PLA groups. ALA therapy appears to reduce significantly d-ROMs and to improve HDL-C value, especially in men with metabolic syndrome treated with oral hypoglycemic drugs. These findings will be useful in patient selection in future clinical trials with ALA in long term studies.


Archives of Gerontology and Geriatrics | 2012

Atrial fibrillation (AF) and cognitive impairment in the elderly: A case–control study

A. Bellomo; G. De Benedetto; E. D’ottavio; V. Formosa; V. Gianturco; A. Iori; Marigliano B; C. Lo Iacono; G. Troisi; Vincenzo Marigliano

AF is able not only to increase the risk of cognitive decline due to acute cerebrovascular events, but also to reduce cardiac output, with the consequence of impaired cerebral perfusion. The aim of this study was to evaluate the association between AF, dementia and depression in patients with negative anamnesis for past strokes. Our sample included 26 patients with a diagnosis of AF (paroxystic, persistent, permanent) and 31 patients with sinus rhythm, enrolled as controls. All selected patients underwent a Multidimensional Geriatric Assessment in order to investigate cognitive and behavioral functions. Statistical analysis of results showed a greater frequency of latent cognitive impairment in patients with AF, even in the absence of memory disorders. As a matter of facts, AF patients showed Mini Mental State Examination (MMSE) scores significantly lower than those with sinus rhythm (p<0.05) and Geriatric Depression Scale (GDS) scores higher than those without AF, evidencing a greater risk of depression too (p<0.02). Results showed a statistically significant association between AF, depression and cognitive impairment in early stage. In conclusion, AF is not only associated with the risk of developing cognitive impairment, but it can also be considered as a risk factor for dementia and depression, even in the absence of medical history of past stroke.


Archives of Gerontology and Geriatrics | 2009

The treatment of hypertension with telmisartan in the sphere of circadian rhythm in metabolic syndrome in the elderly.

V. Formosa; A. Bellomo; A. Iori; V. Gianturco; E. D’ottavio; M. Mancinella; C. Lo Iacono; G. Troisi; Vincenzo Marigliano

This study compares the efficacy of telmisartan with that of valsartan and ramipril in reducing blood pressure (BP) over 24 hrs in the elderly patients with metabolic syndrome (MS). This prospective and open label study analyzed a sample of 60 patients over 65 years of age with hypertension and with MS. At the beginning the BP was monitored by a 24-hr ambulatory blood pressure monitoring (AMBP). Following this, the 60 patients were divided into 3 groups of 20, to each of which was prescribed, respectively, telmisartan, valsartan and ramipril to take for 12 weeks. The drugs were to be taken at 9.00 a.m. Later on the doses were increased. After 12 weeks of therapy, BP was monitored by a 24-hr AMBP. The use of telmisartan caused a greater reduction of the BP in the final 4-6 hours of the period between the 1st administration of the drug and the next one, these last 4-6 hours being those when cardiovascular and cerebrovascular accidents are more frequent (between 6.00 and 10.00 a.m.). Comparing to valsartan and ramipril, telmisartan results in excellent pressure control during the last 4-6 hours between the 1st administration of the drug and the next one.


Archives of Gerontology and Geriatrics | 2010

A rare familiar case of hereditary bisalbuminemia and diabetic predisposition: A possible predictive link?

A. Bellomo; M. Mancinella; G. Troisi; Vincenzo Marigliano

We present a case report of hereditary bisalbuminemia in an Italian family with three affected members. Bisalbuminemia represents a genetic variant of the albumin, it will then be permanent, or acquired and then be transient. It is characterized by the presence of two albumin bands in electrophoresis: the first band with the same mobility of the normal albumin, the second band with a fast variable or a slow variable. The double band of albumin was detected fortuitously on a routine analytical study of an adult woman who was referred to our laboratory with an increase of fasting glucose value, this originated the study of the rest of the members of the family. Finally, it is like the genetic peculiarity of this family core show a possible predictive link between bisalbuminemia on one hand and the predisposition to type II diabetes mellitus on the other hand. As a result of such high probability we are eager to continue further search at our medicine predictive centre.


Recenti progressi in medicina | 2012

Aritmie cardiache in età geriatrica

Giorgio De Benedetto; Roberta De Angelis; Chiara Fossati; A. Bellomo; Maria Alfarano; Marigliano B; Cristina Lo Iacono; Vincenzo Marigliano

The prescription of antiarrhythmic therapy in the elderly depends on the characteristics of clinical symptoms and on the potential morbidity and mortality. Some cardiac arrhythmias may cause bothersome symptoms but do not affect the long-term prognosis. However, other dysrhythmias with mild or no symptoms may be associated with a poor prognosis.The prescription of antiarrhythmic therapy in the elderly depends on the characteristics of clinical symptoms and on the potential morbidity and mortality. Some cardiac arrhythmias may cause bothersome symptoms but do not affect the long-term prognosis. However, other dysrhythmias with mild or no symptoms may be associated with a poor prognosis.


Recenti progressi in medicina | 2011

Insufficienza respiratoria acuta trattata con ventilazione meccanica non invasiva

Formosa; A. Bellomo; Cirene M; D'Ottavio E; Frezza R; Gianturco; A. Iori; Marigliano B; Lo Iacono C; G. Troisi; Marigliano

This is a case of 89 years old patient suffering by chronic obstructive pulmonary disease and affected by acute respiratory failure characterized by hypoxemia and hipercapnia. It is interesting because, comparing oxygen therapy and non invasive ventilation, the best results were reached with the last technique, in an elder patient.This is a case of 89 years old patient suffering by chronic obstructive pulmonary disease and affected by acute respiratory failure characterized by hypoxemia and hipercapnia. It is interesting because, comparing oxygen therapy and non invasive ventilation, the best results were reached with the last technique, in an elder patient.


Recenti progressi in medicina | 2011

Prevalence of depression in a geriatric population with metabolic syndrome

G. Troisi; Formosa; A. Bellomo; Cirene M; D'Ottavio E; Frezza R; Gianturco; A. Iori; Lo Iacono C; Marigliano B; Marigliano

Metabolic Syndrome (Metabolic Syndrome, MS) is associated with many other diseases in the elderly. We have studied a possible correlation between this disorder and depression in a Geriatric Centre. The study was conducted on a random sample of 30 geriatric patients, then divided into 2 groups according to clinical and instrumental diagnostic investigations: 15 patients affected MS according to the criteria of NCEP ATP III, and 15 controls without MS. Then its administered the Geriatric Depression Scale (GDS). Elaboration of the results it appears statistically significant correlation (t=2.05, p=0.0495) between MS and depression in the elderly.Metabolic Syndrome (Metabolic Syndrome, MS) is associated with many other diseases in the elderly. We have studied a possible correlation between this disorder and depression in a Geriatric Centre. The study was conducted on a random sample of 30 geriatric patients, then divided into 2 groups according to clinical and instrumental diagnostic investigations: 15 patients affected MS according to the criteria of NCEP ATP III, and 15 controls without MS. Then its administered the Geriatric Depression Scale (GDS). Elaboration of the results it appears statistically significant correlation (t=2.05, p=0.0495) between MS and depression in the elderly.


Archives of Gerontology and Geriatrics | 2007

Diabetes and metabolic syndrome (MS).

A. Bellomo; M. Mancinella; G. Troisi; Evaristo Ettorre; Vincenzo Marigliano


Hepatology International | 2013

Impact of combined therapy with alpha-lipoic and ursodeoxycolic acid on nonalcoholic fatty liver disease: double-blind, randomized clinical trial of efficacy and safety.

Vincenzo Gianturco; G. Troisi; A. Bellomo; Sciaila Bernardini; Elisa D’Ottavio; Valeria Formosa; Cristina Lo Iacono; Walter Verrusio; Marigliano B; Vincenzo Marigliano

Collaboration


Dive into the A. Bellomo's collaboration.

Top Co-Authors

Avatar

G. Troisi

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

M. Mancinella

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

A. Iori

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Marigliano B

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

V. Gianturco

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

E. D’ottavio

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Evaristo Ettorre

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

V. Formosa

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

C. Lo Iacono

Sapienza University of Rome

View shared research outputs
Researchain Logo
Decentralizing Knowledge